Using a polyclonal anti-human CYP3A4 antibody (detecting CYP34A, 3A5 and 3A7) and recombinant CYP3A4 as a standard, we detected and quantified CYP3A by Western Blotting in all 11 tested breast cancer samples. The gene discussed is CYP3A4; the disease is breast carcinoma.